Answers are grounded in this paper and cite their sources.
Randomized trial finds increased delirium odds with higher benzodiazepine doses in PICU patients, suggesting caution with dosing.
Introduction: Delirium is a common complication of critical illness and a major driver of morbidity in the pediatric intensive care unit (PICU). Several factors, including mechanical ventilation, physical restraints, and the use of benzodiazepines, have been reported to increase risk. Nevertheless, the nature of the interaction between benzodiazepines and delirium, including the possibility of a threshold dose under which benzodiazepines do not increase risk, is not yet well understood. This study aims to determine the risk factors and characterize the relationship of benzodiazepine dose with subsequent delirium in PICU patients. Methods: We conducted a secondary analysis of prospectively collected data from the PICU Up! pilot study, a stepped-wedge cluster randomized trial examining a mobility intervention. Our analysis includes patients from 5 centers admitted to a PICU for ≥ 3 days during the intervention period. We used a logistic regression-based generalized estimating equations model to determine factors associated with delirium and marginal effects to predict the probability of delirium at various benzodiazepine doses. Rate of change in probability by dose was calculated. Results: Our analysis included 856 patients and 4,978 ICU days, with a median PICU stay of 7 days (IQR: 5-13). Increasing benzodiazepine dose was associated with increased odds of delirium (aOR 1.20 per midazolam milligram equivalent, 95% CI: 1.02-1.40, p = 0.030). The risk of delirium increased linearly with the dose of benzodiazepine administered on the previous day. The rate of increase in delirium probability was consistent across percentiles of benzodiazepine dose: 0.024 (95% CI: 0.002-0.046) at the 1st, 5th, 25th, and 50th percentiles. Physical restraints (aOR 1.59, CI: 1.16-2.19, p = 0.004), mechanical ventilation (aOR 2.44, CI: 1.80-3.31, p < 0.001), CPAP or BiPAP (aOR 1.49, CI: 1.09-2.03, p = 0.013), and the presence of delirium on the previous day (aOR 5.44, CI: 4.45-6.66, p < 0.001) were also associated with increased odds of delirium. Conclusions: There is a linear dose-response relationship between benzodiazepines and delirium in the PICU, with even small doses associated with increased risk. Benzodiazepine doses should be limited and alternatives used whenever possible.
No takes yet. Share an insight, caveat, or question.
Blackman et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: